In vitro and in vivo comparative performance studies of gadolinium-loaded zeolites and Gd-DOTA as contrast agents for MRI applications

dc.contributor.authorContro, Janine [UNESP]
dc.contributor.authorSilva, Danilo Antonio [UNESP]
dc.contributor.authorSantisteban, Oscar A. N. [UNESP]
dc.contributor.authorNarayana, Ponnada A.
dc.contributor.authorNery, José G. [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionUniversity of Texas–Health Science Center (UTHealth)
dc.date.accessioned2021-06-25T10:46:12Z
dc.date.available2021-06-25T10:46:12Z
dc.date.issued2021-08-01
dc.description.abstractGadolinium-based contrast agents (CAs) were synthesized using faujasite zeolite (NaX) and zeolite beta (BEA) and their performances in vitro and in vivo were compared to the widely used commercial CA, gadoteric acid (Gd-DOTA). Magnetic resonance imaging (MRI) relaxometry studies (considering longitudinal [T1] and transverse [T2] relaxation times) were performed using Gd-DOTA and the zeolitic materials loaded with Gd3+. The Gd-loaded NaX, which presented large pores and cavities (7.35 and 11.24 Å, respectively), exhibited relaxivity values of around 52 mM−1 s−1, while BEA, which presented smaller pore and cavity diameters (5.95 and 6.68 Å, respectively) showed lower relaxivity values of ~4.8 mM−1 s−1. The effect of the Gd-loaded NaX as MRI CA was tested in vivo in Sprague–Dawley rats, employing a 7 T scanner, with comparison to Gd-DOTA MRI angiography. The relaxivity measurements showed that the Gd-loaded NaX (50 mM−1 s−1) provided better image contrast than Gd-DOTA (5.1 mM−1 s−1). Clearance studies of the CAs using urine and blood showed that both Gd-loaded NaX and Gd-DOTA were eliminated from the body after 2 days, demonstrating the potential of Gd-loaded NaX for use as an MRI CA.en
dc.description.affiliationDepartamento de Física Instituto de Biociências Letras e Ciências Exatas UNESP–Universidade Estadual Paulista
dc.description.affiliationDepartment of Diagnostics and Interventional Imaging University of Texas–Health Science Center (UTHealth)
dc.description.affiliationUnespDepartamento de Física Instituto de Biociências Letras e Ciências Exatas UNESP–Universidade Estadual Paulista
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.description.sponsorshipIdFAPESP: #11/51851
dc.description.sponsorshipIdFAPESP: #19/01858-5
dc.description.sponsorshipIdCNPq: #406761/2013-2
dc.description.sponsorshipIdCNPq: #465594/2014-0
dc.description.sponsorshipIdCAPES: PDSE process 88881.189630/2018-01
dc.format.extent1105-1115
dc.identifierhttp://dx.doi.org/10.1002/jbm.b.34773
dc.identifier.citationJournal of Biomedical Materials Research - Part B Applied Biomaterials, v. 109, n. 8, p. 1105-1115, 2021.
dc.identifier.doi10.1002/jbm.b.34773
dc.identifier.issn1552-4981
dc.identifier.issn1552-4973
dc.identifier.scopus2-s2.0-85097184249
dc.identifier.urihttp://hdl.handle.net/11449/206929
dc.language.isoeng
dc.relation.ispartofJournal of Biomedical Materials Research - Part B Applied Biomaterials
dc.sourceScopus
dc.subjectcontrast agent
dc.subjectgadolinium
dc.subjectGd-DOTA
dc.subjectrelaxivity
dc.subjectzeolite
dc.titleIn vitro and in vivo comparative performance studies of gadolinium-loaded zeolites and Gd-DOTA as contrast agents for MRI applicationsen
dc.typeArtigo

Arquivos